Literature DB >> 9055285

Management of vestibular schwannomas (acoustic neuromas): radiological features in 202 cases--their value for diagnosis and their predictive importance.

C Matthies1, M Samii, S Krebs.   

Abstract

OBJECTIVE: Tumor-induced bony and soft tissue findings might reflect, in part, the biological characteristics of vestibular schwannomas and could predict clinical findings. In addition, the role of the individual anatomic conditions of the posterior fossa is of interest to the surgeon.
METHODS: Of 1000 vestibular schwannomas treated surgically at the neurosurgical department at Nordstadt Hospital, 202 cases, which were consecutively investigated at the same computed tomography (CT) unit and using the same technique (high-resolution CT at bone windows before and after surgery, contrast-enhanced high-resolution CT before surgery, and native high-resolution CT after surgery), were evaluated for special radiological features. Evaluation included, in 103 cases, anatomic parameters of the petrous bone and posterior fossa cavity and, in 202 cases, tumor-induced changes of bony structures, tumor relations with bony structures and with neural structures, and postoperative findings of bony structures and of neural tissues. These radiological parameters and the related clinical pre- and postoperative findings were transferred to a database for statistical evaluation of their positive or negative correlations, i.e., for their reliability in diagnosis and their importance in predicting postsurgical outcome.
RESULTS: As important parameters, the following could be identified. The length of the posterior auditory canal wall and the interear difference of the maximum porus width both correlate with the degree of preoperative hearing deterioration (P < 0.05). The extent of the widening of the internal auditory canal is of predictive importance for the chances of postoperative hearing preservation or hearing loss (P < 0.01). The extent of tumor growth anterior and caudal to the internal auditory canal in large tumors is of significant importance for prediction of postoperative hearing function (P < 0.05). The tumor extension in all directions and the extent of cystic tumor components correlate with the pre- and postoperative function of the facial and cochlear nerves. The positions of the labyrinthine structures and their geographical relations to the fundus and the sigmoid sinus and, thereby, to the suboccipital route, enable reliable calculations of the danger of labyrinthine destruction and help improve the planning of the surgical strategy. DISCUSSION AND
CONCLUSIONS: In addition to the importance for surgical planning, preoperative bone window CT and contrast-enhanced images offer the opportunity to identify traits of tumor biology, such as bony destruction of the internal auditory canal, tumor shape and cyst formation, and aspects with predictive importance for postoperative outcome. The average size for hearing preservation in tumors was 14.5 x 16.5 x 11.8 mm (coronal x sagittal x axial). The recent finding (8) of a higher presentation age in female patients has an apparently anatomic basis, which is a relatively larger internal auditory meatus.

Entities:  

Mesh:

Year:  1997        PMID: 9055285     DOI: 10.1097/00006123-199703000-00009

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  12 in total

1.  Prognostic Indices for Predicting Facial Nerve Outcome following the Resection of Large Acoustic Neuromas.

Authors:  Kurt Grahnke; Jonathan R Garst; Brendan Martin; John P Leonetti; Douglas E Anderson
Journal:  J Neurol Surg B Skull Base       Date:  2017-07-19

2.  Cranial nerve assessment in posterior fossa tumors with fast imaging employing steady-state acquisition (FIESTA).

Authors:  Takeshi Mikami; Yoshihiro Minamida; Toshiaki Yamaki; Izumi Koyanagi; Tadashi Nonaka; Kiyohiro Houkin
Journal:  Neurosurg Rev       Date:  2005-06-03       Impact factor: 3.042

3.  Cystic versus solid vestibular schwannomas: a series of 80 grade III-IV patients.

Authors:  Franco Benech; Rosa Perez; Marco Maria Fontanella; Bruno Morra; Roberto Albera; Alessandro Ducati
Journal:  Neurosurg Rev       Date:  2005-03-01       Impact factor: 3.042

4.  Delayed microsurgery for vestibular schwannoma after gamma knife radiosurgery.

Authors:  Cheng-Chia Lee; Yu-Shu Yen; David Hung-Chi Pan; Wen-Yuh Chung; Hsin-Mei Wu; Wan-Yuo Guo; Ming-Te Chen; Kang-Du Liu; Yang-Hsin Shih
Journal:  J Neurooncol       Date:  2010-04-20       Impact factor: 4.130

Review 5.  The Management and Imaging of Vestibular Schwannomas.

Authors:  E P Lin; B T Crane
Journal:  AJNR Am J Neuroradiol       Date:  2017-05-25       Impact factor: 3.825

6.  Microsurgical treatment of symptomatic vestibular schwannomas in patients under 40: different results before and after age of 30.

Authors:  Luciano Mastronardi; Alberto Campione; Guglielmo Cacciotti; Ettore Carpineta; Carlo Giacobbo Scavo; Raffaele Roperto; Giovanni Stati; Albert A Sufianov; Karl Schaller
Journal:  Neurosurg Rev       Date:  2021-08-17       Impact factor: 3.042

7.  Radiological and Clinical Factors Predicting the Facial Nerve Outcome following Retrosigmoid Approach for Large Vestibular Schwannomas (VSs).

Authors:  Mayur Sharma; Ashish Sonig; Sudheer Ambekar; Anil Nanda
Journal:  J Neurol Surg B Skull Base       Date:  2013-06-25

8.  Hearing preservation in acoustic neuroma resection: Analysis of petrous bone measurement and intraoperative application.

Authors:  Levent Tanrikulu; Peer Lohse; Rudolf Fahlbusch; Ramin Naraghi
Journal:  Surg Neurol Int       Date:  2016-12-12

9.  Morphometric analysis of posterior fossa in Indian CP angle acoustic schwannoma patients.

Authors:  Mohana Rao Patibandla; Manas K Panigrahi; Paniraj L Gurram; Amit Kumar Thotakura; Dilip Kulkarni
Journal:  Asian J Neurosurg       Date:  2016 Jul-Sep

10.  Surgical outcome in cystic vestibular schwannomas.

Authors:  Suresh Nair; Sachin S Baldawa; Chittur Viswanathan Gopalakrishnan; Girish Menon; Vazhayil Vikas; Jayanand B Sudhir
Journal:  Asian J Neurosurg       Date:  2016 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.